Topic - Medtronic

avatar
Biosciences

Medtronic’s Wireless Rejection

Wall Street unfazed by FDA panel’s rejection of company’s wireless heart monitoring device.
avatar
Biosciences

$50M to Rescue Failing Hearts

Startup InnerPulse grabs the funding from venture capital and med-tech companies for implant to help folks survive sudden cardiac arrest.
avatar
Biosciences

Profits Surge at St. Jude

The med-tech giant’s shares tick upward as defibrillator market stabilizes.
avatar
Finance

CardioMEMS Files for IPO

Maker of wireless sensors for heart patients plans to raise $86.3 million.
avatar
Biosciences

Picking Medtronic CEO’s Brain

Investors look to get insight on the medical device industry’s coming year with top chief Art Collins.
avatar
Biosciences

Pharma Shops Biotech at JPMorgan Conference

JPMorgan's annual healthcare confab. highlights trends and themes shaping the sector.
avatar
Biosciences

Building the Bionic Man

Year in Review: Innovation and controversy defined the medical technology industry.
avatar
Biosciences

Medtronic's Brain Pacemaker Tested

Study shows implantable device helps alleviate Parkinson’s symptoms.
avatar
Biosciences

Medtronic Profit Surges

Despite slow defibrillator market, medical device maker reports results in line with lowered expectations.
avatar
Biosciences

Boston Sci’s $381M Indigestion

Medical device maker squirrels away the money to deal with the legal woes of Guidant.
avatar
Biosciences

Xtent Plans $103M IPO

The heart device company hopes to raise funds to pump into drug-eluting stents.
avatar
Biosciences

Drugs & Devices: Stock Shock

Defibrillator sales’ irregular beat; Merck wins Vioxx Case; women’s drugs: $63B by 2010
avatar
Biosciences

Obesity Fight Gets $45.2M Lift

Startup EnteroMedics grabs funding for a device to help the overweight drop the pounds.
avatar
Biosciences, Finance

Medtronic Settles Kickback Case

The device maker pays $40 million to the U.S. government.
avatar
Biosciences, Finance

BSX Warns on Heart Devices

Boston Scientific shares dip 7 percent after warnings some devices could cause problems.
avatar
Biosciences

Drugs & Devices: Testing HIV

HIV test grabs U.S. approval; Medtronic’s stent OK’d in China; kicking cocaine is hard.
avatar
Biosciences, Finance

Drugs & Devices: SEC Probe

SEC questions Cyberonics; CoGenesys grabs $55 million; sensor monitors glucose.
avatar
Computers, Biosciences

Intel: Better Health Inside?

The chip giant teams with electronics and medical companies with an eye toward cheaper, better healthcare.
avatar
Biosciences

St. Jude, IBM Team on Hearts

Device maker partners with Big Blue to develop system that lets doctors test and reprogram defibrillators and pacemakers.
avatar
Biosciences

Stent Carries 2 Drugs at Once

Conor Medsystems implants the first patient with a dual-drug heart device.
Page 1 of 3
1 2 3 >